NRX PHARMACEUTICALS, INC.
Profile
Company Names
NRX PHARMACEUTICALS, INC.
BIG ROCK PARTNERS ACQUISITION CORP.
Addresses
1201 ORANGE STREET, SUITE 600, WILMINGTON, DE 19899
2645 N. FEDERAL HIGHWAY, SUITE 230, DELRAY BEACH, FL 33483
Phone Numbers
484-254-6134
3107342300
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY, COMMERCIAL
Year Incorporated:
2017
State Incorporated:
DELAWARE
Total Amount Raised:
$6,025,000.00
Number of Funding Rounds:
2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2025-01-27
$3,500,000.00
$3,500,000.00
$0.00
1
2017-09-26
$2,525,000.00
$2,750,000.00
$225,000.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
MICHAEL
ABRAMS
EXECUTIVE OFFICER
RICHARD
ACKERMAN
EXECUTIVE OFFICER, DIRECTOR
PATRICK
FLYNN
DIRECTOR
NB DISTRESSED DEBT INVESTMENT FUND LTD
| NB DISTRESSED DEBT FUND LP
| TELCARE, INC.
| PREDILYTICS, INC.
| PHYTEL INC
| COMMON SENSING INC.
| FOODTRUCKR, LLC
| AVENTURA HQ, INC.
| HAZEL TECHNOLOGIES, INC.
| GA-IP OPPORTUNITIES II LLC
| IRONARC OPPORTUNITIES I LLC
| IRONARC OPPORTUNITIES III, LP
| IRONARC OPPORTUNITIES II LLC
| IP VENTURE FUND-III, LLC
| IP VENTURE FUND-II, LLC
| IP VENTURE FUND IV, LLC
| IPV OPPORTUNITY FUND-I LLC
| GA-IP OPPORTUNITIES, LLC
| IRONARC OPPORTUNITIES IV, LP
| IP VENTURE FUND V, LLC
| IRONARC OPPORTUNITIES V, LP
| IRONARC OPPORTUNITIES VIII, LP
| NRX PHARMACEUTICALS, INC.
| IRONARC OPPORTUNITIES IX LP
| IRONARC OPPORTUNITIES XII, LP
| IRONARC OPPORTUNITIES XI, LP
| IRONARC OPPORTUNITIES VI, LP
| IRONARC OPPORTUNITIES XIV, LP
| IRONARC OPPORTUNITIES XVI, LP
| IRONARC OPPORTUNITIES XVII, LP
| IRONARC OPPORTUNITIES XVIII, LP
| IRONARC OPPORTUNITIES XIX, LP
| IRONARC OPPORTUNITIES XX, LP
| IRONARC OPPORTUNITIES XXIII, LP
| IRONARC OPPORTUNITIES XXII, LP
| IRONARC OPPORTUNITIES XXIV, LP
| IRONARC OPPORTUNITIES XXV, LP
| IRONARC OPPORTUNITIES XXI, LP
CHAIM
HURVITZ
DIRECTOR
JONATHAN
JAVITT
EXECUTIVE OFFICER, DIRECTOR
STUART
F.
KOENIG
DIRECTOR
AP AIM DEERFIELD REIT, LLC
| AP AIM LISLE REIT, LLC
| AP VEF SABAL PALM TAMPA REIT, LP
| AP VEF PROMENADE REIT, LP
| AP VEF TEXAS REIT, LP
| AP VEF BANNOCKBURN REIT, LP
| AP VEF CC REIT, LP
| AP VEF TX MF REIT, LP
| AP VEF ORLANDO REIT, LP
| AP AIM ROSEMONT REIT, LLC
| AP VEF SEVEN SPRINGS REIT, LP
| AREA REAL ESTATE OPPORTUNITY FUND VI, LP
| AP VEF COLUMNS II REIT LP
| AP VEF EDGEWATER REIT LP
| AP WCP FRAMINGHAM REIT LLC
| GRAND CHERRY HILL OWNER LLC
| BIG ROCK PARTNERS ACQUISITION CORP.
MICHAEL
TAYLOR
DIRECTOR
CEQUENT PHARMACEUTICALS INC
| UNITED STATES OIL + GAS CORP
| BRAMSHOTT EUROPE FUND PLC
| MIDWEST GROWTH PARTNERS, L.L.L.P.
| MPJ MANAGEMENT, LLC
| BRAMSHOTT EUROPE FUND L.P.
| GROWTH GEEKS INC.
| DECIPHERA PHARMACEUTICALS, LLC
| CLEAR LABS, INC.
| MIDWEST GROWTH PARTNERS II, L.P.
| VIZIV TECHNOLOGIES, LLC
| MONITORED THERAPEUTICS, INC.
| COMMUNE MULTI-FAMILY, LLC
| COMMUNE MAR VISTA INVESTORS, LLC
| COMMUNE VTA INVESTORS, LLC
| MIDWEST GROWTH PARTNERS III, L.P.
| COMMUNE FUND IV, LLC
| COMMUNE FUND V, LLC
| MANITOWOC HOLDING COMPANY, LLC
| MIDWEST GROWTH PARTNERS IV, LP
| PARALLEL 26 INVESTMENT FUND I, LLC
| NRX PHARMACEUTICALS, INC.
| COMMUNE FUND VI, LLC
LORI
B.
WITTMAN
EXECUTIVE OFFICER, DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date

